Cille Norman visits Ochsner in Metairie once a month to participate in the hospital's ALS care program. As part of that program, Norman has recorded 316 custom phrases, such as "I love you," ...

SOUTH SAN FRANCISCO, Calif., Dec. 10, 2021 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that new data were presented at the 32nd International Symposium on ALS/MND ...

LEXINGTON, Mass., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced it has decided to ...

Metagenomi is editing its pipeline, choosing to seek a partner for a program Moderna dropped and axing its amyotrophic lateral sclerosis (ALS) activities in response to setbacks at a competitor. The ...

Voyager Therapeutics (VYGR) has decided to assess alternate payloads related to its gene therapy program for superoxide dismutase 1 amyotrophic lateral sclerosis. Emerging three-month non-human ...

Cytokinetics will stop further testing of its experimental amyotrophic lateral sclerosis drug after an early look at the data found it was unlikely to succeed. The result comes four years after the ...

MEDICAL SERVICE PROGRAM THAT EXETER HOSPITAL IS ENDING. SO RIGHT NOW THERE ARE 13 TOWNS CONTRACTED WITH THE EXETER HOSPITAL ALS PROGRAM. ON MARCH 21ST, THAT PROGRAM WILL BE OFFICIALLY CLOSING. SO THE ...

The Acton Fire Department is celebrating marking the end of the second year of its ALS program. The department officially transitioned from Basic Life Support to Advanced Life Support on Sept. 5, 2017 ...

- All other programs remain on track; IND filings expected in 2025 for GBA1 and FA programs - LEXINGTON, Mass., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (VYGR), a biotechnology ...